Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2025-12-25 @ 11:56 PM
Study NCT ID:
NCT04820894
Status:
WITHDRAWN
Last Update Posted:
2025-05-23
First Post:
2021-03-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Perception of Cure Among Patients With Metastatic Cancer
Sponsor:
City of Hope Medical Center
Organization:
Study Overview
Official Title:
The Perception of Cure Among Patients With Metastatic Cancer
Status:
WITHDRAWN
Status Verified Date:
2025-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Feasibility
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study collects information about perception of cure among patients with cancer that has spread to other places in the body (metastatic). This study aims to determine patients' perception (knowledge) before starting immunotherapy and if differences exist in understanding of treatment to stimulate or restore the ability of the body's immune (defense) system to fight infection and disease (immunotherapy) based on social and economic factors or on race/ethnicity.
Detailed Description:
PRIMARY OBJECTIVE:
I. To assess the proportion of patients with metastatic cancer who anticipate cure before starting immunotherapy.
SECONDARY OBJECTIVES:
I. To determine if expectations of cure are associated with quality of life and distress.
II. To determine if patients' perceptions differ by gender, age, and ethnicity.
OUTLINE:
Patients complete surveys over 30 minutes about sociodemographic information and perception of immunotherapy, over 10 minutes about expectations of cure, over 10 minutes about anxiety, over 10 minutes about depression, and over 30 minutes about physical well-being. Patients' medical records are reviewed.
I. To assess the proportion of patients with metastatic cancer who anticipate cure before starting immunotherapy.
SECONDARY OBJECTIVES:
I. To determine if expectations of cure are associated with quality of life and distress.
II. To determine if patients' perceptions differ by gender, age, and ethnicity.
OUTLINE:
Patients complete surveys over 30 minutes about sociodemographic information and perception of immunotherapy, over 10 minutes about expectations of cure, over 10 minutes about anxiety, over 10 minutes about depression, and over 30 minutes about physical well-being. Patients' medical records are reviewed.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| NCI-2021-01818 | REGISTRY | CTRP (Clinical Trial Reporting Program) | View | |
| 19322 | OTHER | City of Hope Medical Center | View | |
| P30CA033572 | NIH | None | https://reporter.nih.gov/quic… | View |